The study involved a clinical trial of 1,509 insured patients following heart attack with a 12-month intervention taking place from 2013 through 2016. For the study, 1,003 patients participated in an intervention involving electronic pill bottles as well as lottery incentives and social support designed to improve medication adherence, while 506 patients received usual care.
Overall, researchers said they found “no statistically significant differences” between the two groups when it came to “time to first rehospitalization for a vascular event or death,” “time to first all-cause rehospitalization,” or “total number of repeated hospitalizations.”
Additionally, the two groups had the same average medication adherence rate and average medical costs following enrollment.
“A compound intervention integrating wireless pill bottles, lottery-based incentives and social support did not significantly improve medication adherence or vascular readmission outcomes for AMI [acute myocardial infarction] survivors,” the study authors concluded.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
